Dr. David Kaplan Joins Kraig Biocraft Laboratories Scientific Advisory Board
June 06 2011 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced
today that celebrated biomedical researcher Dr. David Kaplan, whose
research interest focuses on the interface between biology and
materials science, with over 35 years of scientific applications
research experience, has joined the Company's Board of Scientific
Advisors.
Dr. Kaplan is internationally recognized for his work relating
to biomedical and other applications for spider silk and
biopolymers. He is the Chairman of Tufts University's Department of
Biomedical Engineering and is the Director of the Bioengineering
and Biotechnology Center. His research focus is on biopolymer
engineering to understand structure-function relationships, with
emphasis on studies related to self-assembly, biomaterials
engineering and functional tissue engineering. He has published
more than 400 papers and edited eight books.
Renowned for his outstanding accomplishments and contributions
in the realms of science and biomedical engineering, Dr. Kaplan has
been awarded numerous honors and awards including Elected Fellow,
American Institute of Medical and Biological Engineering;
Outstanding Faculty Award, Tufts University and the Decoration for
Meritorious Civilian Service, U.S. Government.
"We are very happy to announce that Dr. Kaplan has agreed to
join our board of Scientific Advisors," said Kraig Biocraft
Laboratories founder and CEO, Kim K. Thompson. "There is an obvious
synergy between the Kraig's work in developing and producing
recombinant spider silk and Dr. Kaplan's work in researching and
developing practical applications for biopolymers including spider
silk."
Thompson continued, "We have always been fortunate in being able
to attract the top intellects and talent to both our Scientific
Board of Advisors and our Business Board of Advisors. Dr. Kaplan's
proven track record in the science of biopolymers and biopolymer
applications makes him ideally suited to advise us as we move
toward the production of our own spider silk based
biopolymers."
Additionally, the Company reminds all interested parties that it
will host an informational teleconference on Friday, June 10, 2011
at 4:30 p.m. EDT. Interested parties are invited to submit
questions to benh@ttfsco.com by Thursday, June 9. Call in details,
including phone number and access codes, will be announced in a
follow-up company release on the morning of the call.
Kraig Biocraft Laboratories is a fully reporting biotechnology
company that recently achieved a series of scientific
breakthroughs, with implications for the global textile industry.
For further information, including videos, which outline the
commercial potential that has garnered attention of many scientific
and trade journals, please visit www.KraigLabs.com.
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "implications," "could" or other words or phrases of
similar import. Similarly, statements in this release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals should all be considered forward-looking
statements. All such forward-looking statements are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those in forward-looking statements.
Management cautions that its ability to further its research, and
create commercially-viable products may be affected by the
competitive environment, the Company's financial condition and its
ability to raise sufficient capital to meet the financial
obligations of its business plan and to fund its continuing
operations.
Ben Hansel (720) 288-8495
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024